Michel Voigt Sells Shares of MMSI
Michel Voigt, Chief HR Officer at MMSI, offloaded 65 shares recently.
Key Points
- Michel Voigt, Chief HR Officer of MMSI, sold 65 shares on June 15, 2026.
- MMSI's stock is trading at $67.68, with major institutional holders like BlackRock and Vanguard.
- Analysts from Canaccord Genuity and JP Morgan maintain a 'buy' rating with targets up to $107.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Michel Voigt, the Chief Human Resources Officer at MMSI, recently sold 65 shares of the company. The transaction took place on June 15, 2026. Currently, MMSI's stock is trading at $67.68 per share.
Other Institutional Activity in MMSI
Several large institutional investors have also been active in MMSI. BlackRock, Inc. increased its holdings by 130,940 shares, bringing its total to 8,834,315 shares valued at about $608.9 million. Vanguard Portfolio Management LLC added 3,523,088 shares, now holding 3,523,088 shares worth approximately $242.8 million. Similarly, Vanguard Capital Management LLC and State Street Corp. also increased their stakes, with State Street adding 129,934 shares to hold 2,360,982 shares valued at $162.7 million.
Insider Buying and Selling at Merit Medical Systems, Inc.
In addition to Michel Voigt's sale, Brian Lloyd, Chief Legal Officer and Secretary, sold 2,000 shares on June 5, 2026. Earlier, Thomas Gunderson bought and sold 21,250 shares on May 20, 2026, at an average price of $52.17. Other insiders, including Stephen Evans and Lynne Ward, purchased 3,457 shares each on May 18, 2026.
Analysts Set New Price Targets
On May 1, 2026, Canaccord Genuity maintained a 'buy' rating for MMSI with a price target of $85. JP Morgan also kept its 'buy' rating, setting a target at $77. Wells Fargo maintained a 'hold' rating with a $74 target, while Needham set a target of $90. The consensus among analysts leans towards a 'buy' recommendation, with the average target price around $90.
Bottom Line
Michel Voigt's recent sale of MMSI shares adds to the mix of insider activity at the company. Investors often watch insider transactions closely, but they are just one piece of the puzzle. MMSI's institutional activity shows continued interest, with major holders like BlackRock and Vanguard adjusting their positions. Analysts remain optimistic, maintaining 'buy' ratings with price targets suggesting potential upside. As always, insider sales are not inherently negative and can occur for many personal or strategic reasons.
Get Merit Medical Systems, Inc. alerts
New 13F filings, insider trades, and analyst moves on $MMSI, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.